Temporomandibular joint osteoarthritis (TMJ OA) is a degenerative disease that affects both cartilage and subchondral bone. We used microarray to identify changes in gene expression levels in the TMJ during early stages of the disease, using an established TMJ OA genetic mouse model deficient in 2 extracellular matrix proteins, biglycan and fibromodulin (bgn -/0 fmod -/-). Differential gene expression analysis was performed with RNA extracted from 3-week-old WT and bgn -/0 fmod -/-TMJs with an intact cartilage/subchondral bone interface. In total, 22 genes were differentially expressed in bgn -/0 fmod -/-TMJs, including 5 genes involved in osteoclast activity/differentiation. The number of TRAP-positive cells were three-fold higher in bgn -/0 fmod -/-TMJs than in WT. Quantitative RT-PCR showed up-regulation of RANKL and OPG, with a 128% increase in RANKL/OPG ratio in bgn -/0 fmod -/-TMJs. Histology and immunohistochemistry revealed tissue disorganization and reduced type I collagen in bgn -/0 fmod -/-TMJ subchondral bone. Early changes in gene expression and tissue defects in young bgn -/0 fmod -/-TMJ subchondral bone are likely attributed to increased osteoclast activity. Analysis of these data shows that biglycan and fibromodulin are critical for TMJ subchondral bone integrity and reveal a potential role for TMJ subchondral bone turnover during the initial early stages of TMJ OA disease in this model. KEY WOrDs: temporomandibular disorders, osteoclasts, matrix biology, bone biology osteoarthritis, cartilage. IntrODuctIOn t he temporomandibular joint consists of a fibrocartilaginous condyle, disc, synovial membrane, and subchondral bone. Temporomandibular joint osteoarthritis (TMJ OA) is a degenerative disease involving all TMJ tissues and leads to anatomical changes and severe pain (Scrivani et al., 2008) . While the contribution of the cartilage to the disease pathology is well-studied, little is known about the role of subchondral bone. Emerging studies have implicated a potential role of subchondral bone during TMJ OA pathology, where sclerosis and increased bone metabolism are involved during cartilage degeneration (Jiao et al., 2011; Lories and Luyten, 2011) . Furthermore, the development of new OA therapeutics that target both cartilage and bone highlights the necessity for a better understanding of the role of subchondral bone turnover during OA pathology (Karsdal et al., 2008) .
The small leucine-rich repeat proteoglycans (SLRPs) are a family of extracellular matrix proteins highly expressed in both cartilage and bone (Embree et al., 2010) . A mouse line doubly deficient in 2 members of the SLRP family, biglycan and fibromodulin (bgn -/0 fmod -/-), is a well-established genetic model for TMJ OA (Wadhwa et al., 2005a,b; Embree et al., 2010) . We have previously reported late-stage osteoarthritic changes in both bgn -/0 fmod -/-TMJ cartilage and subchondral bone, including age-dependent cartilage degeneration, osteophyte formation, and sclerosis (Wadhwa et al., 2005a,b) . One advantage of using an experimental, genetic TMJ OA model is the ability to identify early cellular mechanisms that may predispose the animal to lateonset TMJ OA disease phenotype. Specifically, we have shown that Bgn and Fmod modulate cartilage ECM breakdown at an early age, before overt histological cartilage damaged occurred (Embree et al., 2010) . The goal of this study was to identify new genes in cartilage and bone involved during earlystage TMJ OA in this genetic model. Based on these data, we aimed to evaluate cellular and tissue defects in the bgn -/0 fmod -/-TMJ cartilage and subchondral bone.
MAtErIAls & MEthODs

Animals
Male bgn -/0 fmod -/mice and their strain-matched WT counterparts (C57BL/6-129) were used with approval from the ACUC, National Institutes of Health (NIDCR-DIR-#07-414), and generated as previously reported (Embree et al., 2010) . role of subchondral bone during Early-stage Experimental tMJ Osteoarthritis J Dent Res 90(11) 2011 rnA Isolation and Microarray Analysis TMJ condyles with an intact cartilage/subchondral bone interface were dissected from 3-week-old WT and bgn -/0 fmod -/mice ( Fig.  1A , black arrow). Tissue from 3 animals was pooled to create single samples, and 3 independent WT and bgn -/0 fmod -/pooled samples were prepared for analysis. RNA was isolated by Trizol (Invitrogen, Carlsbad, CA, USA), purified with RNeasy Mini Kit (Qiagen, Valencia, CA, USA), and treated with RNAse-free™ DNase (Ambion, Foster City, CA, USA). Synthesis of cDNA, in vitro transcription of biotinlabeled cRNA targets, and fragmentation of target cRNAs were performed following established Affymetrix® procedures (Allen et al., 2009) at the MUSC Proteomics Facility (Charleston, SC, USA). Fragmented cRNA samples were hybridized to Affymetrix® Mouse Genome 430 2.0 microarrays in accordance with manufacturer protocols. Data were normalized by the Bioconductor gcRMA algorithm (Sean and Meltzer, 2007) implemented with the ArrayQuest Web tool (Argraves et al., 2005) and imported into dChip software (Li and Wong, 2001) for comparative analyses. Genes differentially expressed between WT and bgn -/0 fmod -/samples were defined by the criteria: (1) 'present' detection scores in ≥ 2 samples of either group; (2) fold change > 2; and (3) p < 0.05 (unpaired Student's t test). False-discovery rate, estimated by permutation of sample groupings, approximated 19.4%.
histology and Immunohistochemistry
Paraffin-embedded sections from 3-week-old WT and bgn -/0 fmod -/-TMJ condyles were treated as previously described (Embree et al., 2010) . For tissue orientation, every 5 th slide was stained with hematoxylin and eosin (H&E) or tartrate-resistant acid phosphatase (TRAP; Sigma 387A; Sigma, St. Louis, MO, USA). To quantify the percentage of TRAP-positive cells, we counted TRAP-positive cells and total cell number at the cartilage/subchondral bone interface from comparable tissue sections from 3 WT and 3 bgn -/0 fmod -/mice. Three serial sections within fixed areas were counted per mouse.
Immunohistochemistry was performed as previously described (Embree et al., 2010) . Tissue sections were enzymatically treated with ABCase and incubated with primary antibodies and isotype-matched negative controls, including polyclonal rabbit anti-mouse Bgn (1:500 dilution, rabbit total serum, LF-106; Dr. Larry Fisher, NIH), polyclonal rabbit anti-mouse Fmod (1:500 dilution, rabbit total serum, LF-149; Dr. Larry Fisher, NIH), and polyclonal rabbit anti-human type I collagen (1:2000 dilution, rabbit antiserum, LF-68; Dr. Larry Fisher, NIH). (11) 2011 Quantitative rt-Pcr
The cDNA was obtained by reverse-transcription of total RNA with TaqManTM reverse-transcription reagents (Applied Biosystems, Foster City, CA, USA). Primers used for the RT-PCR were designed with Beacon Designer Software (BioRad, Hercules, CA, USA) (Appendix Table 1 ). Real-time PCR was performed as previously described (Embree et al., 2010) . Gene expression levels were normalized to the housekeeping gene s29.
statistical Analysis
Data were collected from a minimum of 3 independent experiments. Statistical analyses were conducted with Student's t test. Any p values < 0.05 were considered statistically significant.
rEsults Differential Gene Expression in the bgn -/0 fmod -/-tMJ cartilage/ subchondral bone Interface
To identify potential new genes involved during early stages of TMJ OA in the bgn -/0 fmod -/genetic mouse model (Wadhwa et al., 2005a,b; Embree et al., 2010) , we used a microarray analysis approach. Microarray analysis detected differential expression of 22 genes in bgn -/0 fmod -/vs. WT samples (Fig. 1B) . Eight genes were down-regulated in bgn -/0 fmod -/samples (Table) and included genes coding for extracellular matrix proteins involved in cartilage degeneration, such as procollagen, type IX, alpha 3 (Jackson et al., 2010) , hyaluronan and proteoglycan link protein 1 (Urano et al., 2010) , procollagen, type II, alpha 1 (Rintala et al., 1997) , procollagen, type IX, alpha 1 (Hu et al., 2006) , and matrilin 3 (van der Weyden et al., 2006) . Mitochondrial ribosomal protein L30, a gene related to mitochondrial energy metabolism, was also down-regulated (Pagliarini et al., 2008) . Interestingly, CART prepropeptide, a peptide of CART that functions to inhibit osteoclasts and bone resorption through the modulation of RANKL expression (Elefteriou et al., 2005) , was also decreased in bgn -/0 fmod -/samples, suggesting that bone metabolism may be changed in the bgn -/0 fmod -/mice. The 14 genes up-regulated in bgn -/0 fmod -/samples included 3 additional genes associated with osteoclast differentiation and/or function [secreted frizzled-related sequence protein 1 (Hausler et al., 2004) , arylsulfatase K (Baron et al., 1990) , solute carrier family 4, member 1 (Wu et al., 2008) ], and 1 gene associated with bone metabolism [protein tyrosine phosphatase, receptor type V (Lee et al., 2007) ] (Table,  asterisks ). Other genes up-regulated included those related to: cytokinesis of chondrocytes [profilin 1 (Bottcher et al., 2009) ], beta secretase cleavage [beta-site APP cleaving enzyme 1 (Vassar et al., 1999) ], stimulation of hematopoietic stem cells [angiopoietinlike 7 ], inflammation and fat metabolism [ribosomal protein S19 (Filip et al., 2009) ], AE binding protein 1 (Majdalawieh et al., 2006) , erythropoiesis and blood cancer [erythroid-associated factor (Hardee et al., 2006) ], and cell adhesion/motility [tetraspanin 33 (Lazo, 2007) ]. Our microarray analysis demonstrated a relatively high false-discovery rate (FDR = 19.4%), indicating the probability that some false-positives were detected.
Therefore, to confirm the findings from our microarray analysis, we tested 3 responding genes by quantitative RT-PCR (Fig. 1C) . RT-PCR confirmed that CART prepropeptide (Cartpt) was downregulated, whereas protein tyrosine phosphatase, receptor type V (Ptprv), and solute carrier family 4 (anion exchanger), member 1 (Slc4a1), were up-regulated in bgn -/0 fmod -/samples.
Increased Osteoclast Activity in the bgn -/0 fmod -/-tMJ cartilage/ subchondral bone Interface Given that the microarray analysis revealed changes in 4 genes related to osteoclast activity/function and 1 gene associated with bone metabolism in bgn -/0 fmod -/samples (Table, asterisks), we speculated that osteoclast activity was altered in bgn -/0 fmod -/-TMJ subchondral bone. We examined osteoclast activity in WT and bgn -/0 fmod -/by TRAP staining and quantitative RT-PCR for RANKL and OPG, 2 genes important for osteoclast activity. In comparison with WT TMJ (Fig. 2C, arrows) , there was an increase in TRAP-positive regions along the cartilage/subchondral bone interface (Fig.  2, orange line) in bgn -/0 fmod -/-TMJ (Fig.  2D, arrows) . Quantification of TRAPpositive cells confirmed that there was a three-fold increase in bgn -/0 fmod -/-TRAPpositive cells (Fig. 2E) . Quantitative RT-PCR, with RNA isolated from WT and bgn -/0 fmod -/-TMJs, demonstrated a significant increase in RANKL (Fig. 2F) and OPG (Fig. 2G ) gene expression levels in bgn -/0 fmod -/-, with relatively greater up-regulation of RANKL (~4.5-fold increase) compared with OPG (~3.5fold increase). Analysis of these data resulted in a 128% increase in RANKL/OPG ratio in bgn -/0 fmod -/and suggested that osteoclast activity was increased in bgn -/0 fmod -/-TMJ subchondral bone. However, differential expression of RANKL and OPG was not detected in microarray studies (Appendix Table 2 ). This was likely due to the statistical limitations of the microarray analysis and the increased specificity of quantitative RT-PCR. Identification of tMJ subchondral bone Defects in the bgn -/0 fmod -/-tMJ We proposed that increased osteoclast activity would cause phenotypic defects in bgn -/0 fmod -/-TMJ subchondral bone. We examined the subchondral region from 3-week-old bgn -/0 fmod -/-TMJ compared with WT controls by histology (Figs. 3A-D) and immunohistochemistry (Figs. 3E-F) . H&E staining of WT TMJ (Fig. 3A) showed distinct bone marrow cavities formed, which were surrounded by trabecular bone tissue ( Fig. 3C ; orange dashed lines indicate higher magnification). However, H&E stains of bgn -/0 fmod TMJ (Fig. 3B ) revealed significant tissue disorganization and sparse bone tissue present in comparable regions ( Fig. 3D ; orange dashed lines indicate higher magnification). To confirm the presence of subchondral bone defects in the bgn -/0 fmod -/-, we examined type I collagen expression immunohistochemistry. Type I collagen was localized within WT TMJ subchondral bone (Fig. 3E, red) , and a clear decrease was apparent in the bgn -/0 fmod -/-TMJ (Fig. 3F, red) , confirming that less type I collagen-rich bone was present. Interestingly, while type I collagen protein expression was decreased in bgn -/0 fmod -/-TMJs, type I collagen mRNA was not detected, as differentially expressed by microarray analysis (Appendix Table 2 ) or by quantitative RT-PCR (Appendix Fig.) , suggesting that type I collagen production is unchanged. Taken together, our histological findings suggested that the absence of Bgn and Fmod led to less bone in the TMJ subchondral bone region in mice. Immunohistochemistry showed that both Bgn (Fig. 3G, red , arrows) and Fmod (Fig. 3H, red, arrows) were both highly expressed and co-localized in WT TMJ at 3 wks in the bone regions shown to be affected by their absence.
DIscussIOn
The bgn -/0 fmod -/mouse is an established TMJ OA genetic model demonstrating a chronological sequence of cellular/histological evidence that signifies TMJ OA pathology (Wadhwa et al., 2005a,b; Embree et al., 2010) . We took advantage of this genetic model to identify early changes in gene expression levels that may predispose the animal to the late-onset TMJ OA phenotype. Using microarray analysis, we discovered 22 genes differentially expressed in young bgn -/0 fmod -/-TMJs that could potentially be involved in disease initiation. Genes that correspond to other ECM proteins involved in cartilage degeneration in other genetic mouse models were also down-regulated in the bgn -/0 fmod -/samples, including procollagen, type IX, alpha 3 (Jackson et al., 2010) , procollagen, type II, alpha 1 (Rintala et al., 1997) , procollagen, type IX, alpha 1 (Hu et al., 2006), and matrilin 3 (van der Weyden et al., 2006) . Analysis of these data based on genetic mouse models highlights the possibility that, in humans, the loss/mutation of a single ECM-related gene may initiate pathology or increase susceptibility to TMJ disease. However, the factors that account for the majority of TMJ OA cases in humans, which occur with a high predilection in women during childbearing ages, remain unresolved (Scrivani et al., 2008) . TMJ OA genetic mouse models with ECM-related mutations show pathology in aged males (Rintala et al., 1997; Wadhwa et al., 2005a,b; Hu et al., 2006) , thus raising doubt as to whether existing genetic mouse models exhibit TMJ disease analogous to the human condition. It is possible that changes in sex-related hormones may act upstream to contribute to the abnormal expression patterns of ECM-related proteins (Hellio Le Graverand et al., 2000; Talwar et al., 2006; Salgado et al., 2009) . Therefore, for a more comparable model of TMJ OA to be developed, it would be important to determine the effects of estrogen levels on TMJ disease in females, using bgn -/0 fmod -/mice or other genetic mouse models of TMJ OA.
The TMJ has unique properties compared with other articular joints like the knee, because it is made of fibrocartilage and acts both as an articular joint cartilage and as a site for endochondral ossification (Shen and Darendeliler, 2005) . Consequently, the cellular events within the TMJ cartilage/subchondral bone interface are more likely to play a greater role in tissue homeostasis and disease in the TMJ than in the knee joint. TMJ OA is a degenerative disease of the entire joint, including the subchondral bone (Lories and Luyten, 2011) . Phenotypic changes in the subchondral bone in osteoarthritic tissue from both animals and humans have been well-documented, including altered trabecular bone structure, sclerosis, and increased bone resorption/formation (Lories and Luyten, 2011) . Our microarray analysis revealed that at least 5 genes are changed in bgn -/0 fmod -/samples that are related to osteoclast function/differentiation and bone turnover, including CART prepropeptide (Elefteriou et al., 2005) , secreted frizzled-related sequence protein 1 (Hausler et al., 2004) , arylsulfatase K (Baron et al., 1990) , solute carrier family 4, member 1 (Wu et al., 2008) , and protein tyrosine phosphatase, receptor type V (Lee et al., 2007) . More specifically, CART prepropeptide inhibits bone resorption by modulating RANKL expression (Elefteriou et al., 2005) . Similar to bgn -/0 fmod -/mice, mice deficient in CART also have low trabecular bone mass (Elefteriou et al., 2005) . Furthermore, secreted frizzled-related sequence protein 1 is expressed by osteoblasts and inhibits osteoclast formation, suggesting that bone turnover may be higher in the bgn -/0 fmod -/-TMJ subchondral bone (Hausler et al., 2004) . In addition, solute carrier family 4, member 1 (Slc4a1), a bicarbonate/chloride exchanger closely related to Slc4a2, is also up-regulated in bgn -/0 fmod -/samples. This latter protein is a critical mediator of both osteoclast differentiation and function, where Slc4a2 -/osteoclasts are unable to resorb mineralized tissue and fail to express TRAP activity (Wu et al., 2008) . Taken together, these microarray findings suggested that osteoclast activity and/or bone turnover may be increased in the bgn -/0 fmod -/-TMJ subchondral bone.
To explore osteoclast activity in the bgn -/0 fmod -/mice, we examined TRAP stainings in the TMJ subchondral bone and also OPG and RANKL by quantitative RT-PCR. In agreement with our microarray findings, we discovered increased TRAP staining specifically localized along the bgn -/0 fmod -/-TMJ cartilage/subchondral bone interface, suggesting active bone turnover in this region. Similarly, we discovered a 128% increase in OPG/RANKL gene expression ratio in bgn -/0 fmod -/samples, which could cause increased TMJ subchondral bone turnover in bgn -/0 fmod -/mice. In support of our findings, previous studies have demonstrated that non-TMJ OA joints also display increased subchondral bone turnover (Goker et al., 2000) . Moreover, increased osteoclast activity in bgn -/0 fmod -/mice was also coupled with increased chondrogenesis in 3-week-old mice (Embree et al., 2010) . This concept raises the possibility that crosstalk between the cartilage and subchondral bone interface during younger ages is critical for maintaining tissue homeostasis. The disruption of bone and cartilage metabolism in younger bgn -/0 fmod -/mice could disrupt the overall TMJ tissue homeostasis and predispose the mice to the late-onset TMJ OA phenotype previously reported in the older bgn -/0 fmod -/mice, including osteophyte formation, TMJ subchondral bone sclerosis, and cartilage degeneration (Wadhwa et al., 2005a,b) .
We further show that a possible consequence of high bone turnover is defective trabecular bone structure formed in bgn -/0 fmod -/-TMJ subchondral region, as evidenced by histology and type I collagen immunostaining. Given that the functional integrity of the cartilage can depend on the mechanical properties of the underlying bone (Bailey et al., 2004) , it is possible that the disorganized and defective TMJ subchondral bone in bgn -/0 fmod -/mice contributes significantly to TMJ OA pathology. Interestingly, while type I collagen protein expression was decreased in bgn -/0 fmod -/-TMJs, type I collagen mRNA was unchanged. We speculate that the production of type I collagen mRNA is not changed, and that other things such as translational control of type I collagen mRNA or ECM resorption cause less type I collagen protein expression in bgn -/0 fmod -/-TMJs. Given that TRAP-positive cells and RANKL/OPG gene expression levels are significantly higher in bgn -/0 fmod -/-TMJs, it is likely that there is increased resorption and, therefore, less type I collagen protein expression. Taken together, we show for the first time that Bgn and Fmod are critical for the integrity of TMJ subchondral bone and reveal a potential role for subchondral bone turnover during early stages of TMJ OA in this mouse model.
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